Use of medicated drops and oral tablets in glaucoma treatment

Current Opinion in Ophthalmology

Volumn 7, Issue 2, 1996, Pages 44-46

  Greenwell, Catherine ^a   Spillman, Diana ^a  

^a MIAMI UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADRENALIN; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIGLAUCOMA AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBONATE DEHYDRATASE INHIBITOR; CHOLINESTERASE INHIBITOR; DEMECARIUM; DICLOFENAMIDE; DYFLOS; EYE DROPS; METHAZOLAMIDE; MIOTIC AGENT; RESERPINE; SUXAMETHONIUM; TIMOLOL;

BRADYCARDIA; DEPRESSION; DRUG ADMINISTRATION; DRUG EFFICACY; FATIGUE; GASTROINTESTINAL SYMPTOM; GLAUCOMA; HEADACHE; HUMAN; LETHARGY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW; TABLET; TOPICAL DRUG ADMINISTRATION; TRABECULECTOMY; TRABECULOPLASTY; VISUAL IMPAIRMENT;

EID: 0029737441     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/00055735-199604000-00008     Document Type: Review

References (23)

1. Thylefores B, Negrel AD: The global impact of glaucoma. Bull World Health Organ, 1994, 3:323-326. In this article the authors constructed a group of models that give an estimation of the prevalence of glaucoma on a universal scale. A global definition was created, enabling the researchers to make more accurate assessments about glaucoma for the models.
2. Faye EE, Stuen CS, eds: The Aging Eye and Low Vision. New York: Lighthouse Inc; 1992.
3. Shields BM: Textbook of Glaucoma. Baltimore: Williams and Wilkins; 1992.
4. Karlin JD: Diagnosis and therapy of open-angle glaucoma. J Am Acad Physician Assist 1991, 4:573-581.
5. Weiss R: Eyeing the optic nerve. Sci News 1995, 138:330-331.
6. The Glaucoma Foundation: A World Without Blindness. New York: 1994.
7. Roden DR: The prevalence and cost of glaucoma: glaucoma detection and treatment. Proceedings of the First National Glaucoma Conference 1995. Tarpon Springs: National Society to Prevent Blindness; 1980:20.
8. Wormald RPL, Basauri E, Wright LA, Evens JR: The African Caribbean Eye Survey: risk factors for glaucoma in a sampling of African Caribbean people living in London. Eye 1994, 8:315-320. This article summarizes a study of the prevalence of glaucoma in a group of African Caribbean people. In the discussion section, the authors address many of the risk factors for glaucoma that were suspected of increasing intraocular pressure.
9. Tielsch JM, Katz J, Sommer A, Quigley HA, Javitt JC: Family history and risk of primary open angle glaucoma. Arch Ophthalmol 1994, 112:69-73. In this article, the authors used data from the Baltimore Eye Survey to study the association between family history and POAG. They concluded that a positive family history is an important risk factor to consider.
10. Gerali PS, DiVerde M: Glaucoma high risk alert. J Ophthalmic Nurs Technol 1991, 10:34-36.
11. National Society to Prevent Blindness: Vision Problems in the US. New York: 1980.
12. Tielsch JM, Sommer A, Katz J, Royall RM, Quigley HA, Javitt J: Racial variation in the prevalence of primary open-angle glaucoma. JAMA 1991, 266:369-374.
13. Cowan CL Jr, Worthen DM, Mason RP, Anduze AL: Glaucoma in blacks. Arch Ophthalmol 1980, 106:738-739.
14. Martin MJ, Sommer A, Gold EB, Diamond EL: Race and primary open-angle glaucoma. Am J Ophthalmol 1985, 99:383-387.
15. Kahn HA, Milton RC: Alternative definitions of open-angle glaucoma: effect on prevalence and associations in the Framingham Eye Study. Arch Ophthalmol 1980, 98:2172-2177.
16. Clark EE: A comparative analysis of the age distribution and types of primary glaucoma among populations of African and Caucasian origins. Ann Ophthalmol 1971, 3:1055-1071.
17. Wallace J, Lovell HG: Glaucoma and intraocular pressure in Jamaica. Am J Ophthalmol 1969, 67:93-100.
18. The Glaucoma Foundation: Glaucoma: A Guide for Patients and Their Families. 1994. A number of treatments for glaucoma are discussed in this booklet including topical drops such as miotics, epinephrine, dipivefrin, beta-blockers, and betaxolol. In addition the oral medication carbonic anhydrase inhibitors and their side effects are mentioned.
19. Prevent Blindness America: Glaucoma Patient Resource. Schaumburg, IL:1995:9-22.
20. Physicians' Desk Reference, edn. 48 Montvale, NJ: Medical Economics Data Production Co., 1995.
21. Taniguchi T, Yoshiaki K: A risk-benefit assessment of drugs used in management of glaucoma. Drug Saf 1994, 11,68-74. This article discusses some of the negative affects of antiglaucoma drugs that are used to lower intraocular pressure. More specifically, the authors discuss adverse effects of the following categories of drugs: cholinergic drugs, adrenergic agonists, adrenergic antagonists, carbonic anhydrase inhibitors, and hyperosmotic agents.
22. Zimmerman T: How to apply eye drops properly and why it is important. Eye to Eye 1994, 5:4. In this article, the author discusses the importance of proper drop instillation in the reduction of side effects caused by topical drops. Proper application methods of topical drops is also discussed.
23. Proper Drop Instillation. The Glaucoma Foundation. 1994.